TrialBreast cancer research and treatment2017

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Cynthia A Thomson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.